Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) EBIT Margin: 2020-2025

Historic EBIT Margin for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to 9.15%.

  • Agilon Health's EBIT Margin rose 600.0% to 9.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.41%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 4.82% for FY2024, which is 5600.0% up from last year.
  • Agilon Health's EBIT Margin amounted to 9.15% in Q3 2025, which was up 600.0% from 8.32% recorded in Q2 2025.
  • In the past 5 years, Agilon Health's EBIT Margin ranged from a high of 0.04% in Q1 2023 and a low of 59.8% during Q2 2021
  • In the last 5 years, Agilon Health's EBIT Margin had a median value of 4.25% in 2022 and averaged 8.96%.
  • Its EBIT Margin has fluctuated over the past 5 years, first plummeted by -593700bps in 2021, then skyrocketed by 566600bps in 2022.
  • Over the past 5 years, Agilon Health's EBIT Margin (Quarter) stood at 17.35% in 2021, then rose by 16bps to 14.62% in 2022, then dropped by -6bps to 15.56% in 2023, then soared by 54bps to 7.1% in 2024, then decreased by -29bps to 9.15% in 2025.
  • Its EBIT Margin stands at 9.15% for Q3 2025, versus 8.32% for Q2 2025 and 1.44% for Q1 2025.